Shionogi broadens links with academia in CNS research push
This article was originally published in Scrip
Executive Summary
Shionogi is one of the more active pharma companies in Japan when it comes to tapping into the expertise of the academic sector, with which it has been running collaborative programs for several years already to seek out and encourage innovative drug discovery themes and technology.